Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection
2022-01-01 Barone, M; Venerito, V; Paolillo, R; Emmi, G; Fornaro, M; Cacciapaglia, F; Cantarini, L; Di Leo, A; Iannone, F; Lopalco, G.
The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment
2014-01-01 Cacciapaglia, F; Buzzulini, F; Arcarese, L; Ferraro, E; Afeltra, A
Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group
2022-01-01 Cacciapaglia, F; Spinelli, Fr; Piga, M; Erre, Gl; Sakellariou, G; Manfredi, A; Viapiana, O; Fornaro, M; Colella, S; Floris, A; Mangoni, Aa; Castagna, F; Vacchi, C; Orsolini, G; Bugatti, S; Cafaro, G; Cauli, A; Gremese, E; Atzeni, F; Bartoloni, E.
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus
2020-01-01 Fornaro, M; Coladonato, L; Venerito, V; Cacciapaglia, F; Lopalco, G; Iannone, F.
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
2019-01-01 Venerito, V; Lopalco, G; Cacciapaglia, F; Fornaro, M; Iannone, F
The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement
2006-01-01 Amoroso, A; Cacciapaglia, F; De Castro, S; Battagliese, A; Coppolino, G; Galluzzo, S; Vadacca, M; Afeltra, A
Predictors of long-term clinical remission in rheumatoid arthritis
2021-01-01 Fornaro, M; Cacciapaglia, F; Lopalco, G; Venerito, V; Iannone, F.
Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre
2021-01-01 Cacciapaglia, F; Renna, D; Fornaro, M; Venerito, V; Lopalco, G; Iannone, F.
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases
2022-01-01 Ursini, F; Ruscitti, P; Raimondo, V; De Angelis, R; Cacciapaglia, F; Et, Al.
Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus
2013-01-01 Vadacca, M; Zardi, Em; Margiotta, D; Rigon, A; Cacciapaglia, F; Arcarese, L; Buzzulini, F; Amoroso, A; Afeltra, A
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
2021-01-01 Fornaro, M; Righetti, G; Abbruzzese, A; Lopalco, G; Cacciapaglia, F; Anelli, Mg; Venerito, V; Iannone, F.
Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus
2021-01-01 Cafarelli, F; Coladonato, L; Lopalco, G; Cacciapaglia, F; Cantarini, L; Iannone, F.
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs
2005-01-01 Zardi, Em; Zardi, Dm; Cacciapaglia, F; Dobrina, A; Amoroso, A; Picardi, A; Afeltra, A
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature
2022-01-01 Ferri, C; De Angelis, R; Giuggioli, D; Bajocchi, G; Dagna, L; Zanframundo, G; Foti, R; Cacciapaglia, F; Et, al. SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology).
Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients
2009-01-01 Cacciapaglia, F; Zardi, Em; Coppolino, G; Buzzulini, F; Margiotta, D; Arcarese, L; Vadacca, M; Amoroso, A; Afeltra, A
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al
2020-01-01 Fornaro, M; Cacciapaglia, F; Venerito, V; Lopalco, G; Iannone, F.
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis
2020-01-01 Venerito, V; Lopalco, G; Cacciapaglia, F; Coladonato, L; Iannone, F.
Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels
2006-01-01 Bruni, R; Serino, Fm; Galluzzo, S; Coppolino, G; Cacciapaglia, F; Vadacca, M; Nilo, S; Terminio, N; Afeltra, A
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis
2020-01-01 Iannone, F; Nivuori, M; Fornaro, M; Venerito, V; Cacciapaglia, F; Lopalco, G.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
2021-01-01 Ferri, C; Ursini, F; Gragnani, L; Raimondo, V; Giuggioli, D; Foti, R; Caminiti, M; Olivo, D; Cuomo, G; Visentini, M; Cacciapaglia, F; Pellegrini, R; Pigatto, E; Urraro, T; Naclerio, C; Tavoni, A; Puccetti, L; Varcasia, G; Cavazzana, I; L'Andolina, M; Ruscitti, P; Vadacca, M; Gigliotti, P; La Gualana, F; Cozzi, F; Spinella, A; Visalli, E; Dal Bosco, Y; Amato, G; Masini, F; Pagano Mariano, G; Brittelli, R; Aiello, V; Caminiti, R; Scorpiniti, D; Rechichi, G; Ferrari, T; Monti, M; Elia, G; Franceschini, F; Meliconi, R; Casato, M; Iannone, F; Giacomelli, R; Fallahi, P; Santini, Sa; Zignego, Al; Antonelli, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infection | 1-gen-2022 | Barone, M; Venerito, V; Paolillo, R; Emmi, G; Fornaro, M; Cacciapaglia, F; Cantarini, L; Di Leo, A; Iannone, F; Lopalco, G. | |
| The Use of an Interferon-Gamma Release Assay as a Biomarker of Response to Anti-TNF-Alpha Treatment | 1-gen-2014 | Cacciapaglia, F; Buzzulini, F; Arcarese, L; Ferraro, E; Afeltra, A | |
| Estimated 10-year cardiovascular risk in a large Italian cohort of rheumatoid arthritis patients: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group | 1-gen-2022 | Cacciapaglia, F; Spinelli, Fr; Piga, M; Erre, Gl; Sakellariou, G; Manfredi, A; Viapiana, O; Fornaro, M; Colella, S; Floris, A; Mangoni, Aa; Castagna, F; Vacchi, C; Orsolini, G; Bugatti, S; Cafaro, G; Cauli, A; Gremese, E; Atzeni, F; Bartoloni, E. | |
| Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus | 1-gen-2020 | Fornaro, M; Coladonato, L; Venerito, V; Cacciapaglia, F; Lopalco, G; Iannone, F. | |
| A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis | 1-gen-2019 | Venerito, V; Lopalco, G; Cacciapaglia, F; Fornaro, M; Iannone, F | |
| The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement | 1-gen-2006 | Amoroso, A; Cacciapaglia, F; De Castro, S; Battagliese, A; Coppolino, G; Galluzzo, S; Vadacca, M; Afeltra, A | |
| Predictors of long-term clinical remission in rheumatoid arthritis | 1-gen-2021 | Fornaro, M; Cacciapaglia, F; Lopalco, G; Venerito, V; Iannone, F. | |
| Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre | 1-gen-2021 | Cacciapaglia, F; Renna, D; Fornaro, M; Venerito, V; Lopalco, G; Iannone, F. | |
| Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases | 1-gen-2022 | Ursini, F; Ruscitti, P; Raimondo, V; De Angelis, R; Cacciapaglia, F; Et, Al. | |
| Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus | 1-gen-2013 | Vadacca, M; Zardi, Em; Margiotta, D; Rigon, A; Cacciapaglia, F; Arcarese, L; Buzzulini, F; Amoroso, A; Afeltra, A | |
| High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry. | 1-gen-2021 | Fornaro, M; Righetti, G; Abbruzzese, A; Lopalco, G; Cacciapaglia, F; Anelli, Mg; Venerito, V; Iannone, F. | |
| Successful treatment with anakinra of refractory pericarditis in systemic lupus erythematosus | 1-gen-2021 | Cafarelli, F; Coladonato, L; Lopalco, G; Cacciapaglia, F; Cantarini, L; Iannone, F. | |
| Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs | 1-gen-2005 | Zardi, Em; Zardi, Dm; Cacciapaglia, F; Dobrina, A; Amoroso, A; Picardi, A; Afeltra, A | |
| Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature | 1-gen-2022 | Ferri, C; De Angelis, R; Giuggioli, D; Bajocchi, G; Dagna, L; Zanframundo, G; Foti, R; Cacciapaglia, F; Et, al. SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). | |
| Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients | 1-gen-2009 | Cacciapaglia, F; Zardi, Em; Coppolino, G; Buzzulini, F; Margiotta, D; Arcarese, L; Vadacca, M; Amoroso, A; Afeltra, A | |
| Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al | 1-gen-2020 | Fornaro, M; Cacciapaglia, F; Venerito, V; Lopalco, G; Iannone, F. | |
| Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis | 1-gen-2020 | Venerito, V; Lopalco, G; Cacciapaglia, F; Coladonato, L; Iannone, F. | |
| Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels | 1-gen-2006 | Bruni, R; Serino, Fm; Galluzzo, S; Coppolino, G; Cacciapaglia, F; Vadacca, M; Nilo, S; Terminio, N; Afeltra, A | |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis | 1-gen-2020 | Iannone, F; Nivuori, M; Fornaro, M; Venerito, V; Cacciapaglia, F; Lopalco, G. | |
| Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups | 1-gen-2021 | Ferri, C; Ursini, F; Gragnani, L; Raimondo, V; Giuggioli, D; Foti, R; Caminiti, M; Olivo, D; Cuomo, G; Visentini, M; Cacciapaglia, F; Pellegrini, R; Pigatto, E; Urraro, T; Naclerio, C; Tavoni, A; Puccetti, L; Varcasia, G; Cavazzana, I; L'Andolina, M; Ruscitti, P; Vadacca, M; Gigliotti, P; La Gualana, F; Cozzi, F; Spinella, A; Visalli, E; Dal Bosco, Y; Amato, G; Masini, F; Pagano Mariano, G; Brittelli, R; Aiello, V; Caminiti, R; Scorpiniti, D; Rechichi, G; Ferrari, T; Monti, M; Elia, G; Franceschini, F; Meliconi, R; Casato, M; Iannone, F; Giacomelli, R; Fallahi, P; Santini, Sa; Zignego, Al; Antonelli, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista10033
Data di pubblicazione
- In corso di stampa26
- 2020 - 20264514
- 2010 - 20193759
- 2000 - 20091284
- 1990 - 1999374
- 1980 - 198975
- 1977 - 19791
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...112
- JOURNAL OF CLINICAL MEDICINE96
- PLOS ONE79
- EUROPEAN HEART JOURNAL69
- CANCERS64
- NUTRIENTS64
- THROMBOSIS AND HAEMOSTASIS60
- MOVEMENT DISORDERS56
- NMCD. NUTRITION METABOLISM AND CA...56
- SCIENTIFIC REPORTS56
Keyword
- Humans317
- Male154
- Female147
- COVID-19124
- Aged108
- Middle Aged99
- Italy94
- Cardiology and Cardiovascular Med...88
- Adult85
- Medicine (all)61
Lingua
- eng6259
- ita928
- fre12
- spa11
- ger3
- und2
- afr1
- bul1
- lat1
Accesso al fulltext
- no fulltext10033